| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
8-K: Results of Operations and Financial Condition; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
COMMACK, NY, Oct. 13, 2026 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physician... |
| 07 Oct 2026 |
8-K: Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year +1 more
COMMACK, NY, September 30, 2026 (GLOBE NEWSWIRE) – SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, phys... |
| 18 Sep 2026 |
Proxy statement: annual meeting on October 28, 2026
say-on-pay vote |
| 14 Sep 2026 |
8-K: Regulation FD Disclosure
On September 14, 2026, Scienture Holdings, Inc. (the “Company”) posted a revised investor presentation (the “Presentation”) to its website at www.scientureholdings.com. The Company intends to present at various meetings with analysts, po... |
| 08 Sep 2026 | PRE 14A |
| 31 Aug 2026 |
Form 5: Sherb Eric Michael, Chief Financial Officer
Received 50,000 shares as a grant or award |
| 31 Aug 2026 |
Form 3: Sherb Eric Michael, Chief Financial Officer
Holds 0 shares of No securities are beneficially owned. |
| 20 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 13 Aug 2026 | 10-Q |
| 29 May 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 22 May 2026 | 8-K: Results of Operations and Financial Condition |
| 15 May 2026 | 10-Q |
| 05 May 2026 | 8-K: Regulation FD Disclosure |
| 01 May 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |
| 30 Apr 2026 | 10-K/A |
| 30 Mar 2026 | 10-K |
| 12 Mar 2026 |
Form 4: Shankar Hariharan, Director
Received 2,273,296 shares by conversion · Disposed of 30,000 shares (Other Transaction) · Received 750,000 shares as a grant or award · 2 more |
| 12 Mar 2026 |
Form 4: Narasimhan Mani, Director
Received 1,357,538 shares by conversion · Disposed of 20,000 shares (Other Transaction) · Received 750,000 shares as a grant or award · 2 more |
| 18 Nov 2025 | 8-K: Regulation FD Disclosure |
| 14 Nov 2025 | SCHEDULE 13G/A |
Loading...
